Suppr超能文献

物理化学性质在毒理学结果预测中的应用:武田视角

Utility of Physicochemical Properties for the Prediction of Toxicological Outcomes: Takeda Perspective.

作者信息

Yukawa Tomoya, Naven Russell

机构信息

Drug Safety Research and Evaluation, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 35 Landsdowne Street, Cambridge, Massachusetts 02139, United States.

Drug Safety Research and Evaluation, Pharmaceutical Research Division, Takeda Pharmaceuticals International Company Limited, 9625 Towne Centre Drive, San Diego, California 92121, United States.

出版信息

ACS Med Chem Lett. 2020 Jan 29;11(2):203-209. doi: 10.1021/acsmedchemlett.9b00536. eCollection 2020 Feb 13.

Abstract

The role that physicochemical properties play toward increasing the likelihood of toxicity findings in studies has been well reported, albeit sometimes with different conclusions. We decided to understand the role that physicochemical properties play toward the prediction of toxicological outcomes for Takeda chemistry using 284 internal compounds. In support of the previously reported "3/75 rule", reducing lipophilicity of molecules decreases toxicity odds noticeably; however, we also found that the trend of toxicity odds is different between compounds classified by their ionization state. For basic molecules, the odds of toxicity outcomes were significantly impacted by both lipophilicity and polar surface area, whereas neutral molecules were impacted less so. Through an analysis of several project-related compounds, we herein demonstrate that the utilization of the 3/75 rule coupled with consideration of ionization state is a rational strategy for medicinal chemistry design of safer drugs.

摘要

物理化学性质在研究中对增加毒性发现可能性所起的作用已有充分报道,尽管有时会得出不同结论。我们决定利用284种内部化合物来了解物理化学性质对武田化学毒理学结果预测所起的作用。支持先前报道的“3/75规则”,降低分子的亲脂性会显著降低毒性几率;然而,我们还发现,根据电离状态分类的化合物之间毒性几率的趋势有所不同。对于碱性分子,毒性结果的几率受亲脂性和极性表面积的显著影响,而中性分子受影响较小。通过对几种与项目相关的化合物的分析,我们在此证明,结合电离状态考虑使用3/75规则是药物化学设计更安全药物的合理策略。

相似文献

5
Overview on the Rule of Five.五规则概述。
Curr Protoc Pharmacol. 2010 Jun;Chapter 9:Unit 9.12. doi: 10.1002/0471141755.ph0912s49.
6
Physiochemical drug properties associated with in vivo toxicological outcomes.与体内毒理学结果相关的物理化学药物性质。
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4872-5. doi: 10.1016/j.bmcl.2008.07.071. Epub 2008 Jul 24.

引用本文的文献

2
Advances in molecular pathology and therapy of non-small cell lung cancer.非小细胞肺癌分子病理学与治疗的进展
Signal Transduct Target Ther. 2025 Jun 15;10(1):186. doi: 10.1038/s41392-025-02243-6.

本文引用的文献

2
Amine promiscuity and toxicology analysis.胺类的混杂性与毒理学分析。
Bioorg Med Chem Lett. 2017 Feb 1;27(3):653-657. doi: 10.1016/j.bmcl.2016.11.085. Epub 2016 Nov 29.
5
Toxicology Strategies for Drug Discovery: Present and Future.药物发现的毒理学策略:现状与未来
Chem Res Toxicol. 2016 Apr 18;29(4):473-504. doi: 10.1021/acs.chemrestox.5b00407. Epub 2015 Dec 4.
7
Volume of Distribution in Drug Design.药物设计中的分布容积。
J Med Chem. 2015 Aug 13;58(15):5691-8. doi: 10.1021/acs.jmedchem.5b00201. Epub 2015 Apr 1.
8
Acidic and basic drugs in medicinal chemistry: a perspective.药用化学中的酸碱药物:一个视角。
J Med Chem. 2014 Dec 11;57(23):9701-17. doi: 10.1021/jm501000a. Epub 2014 Sep 18.
10
The influence of lipophilicity in drug discovery and design.亲脂性在药物发现和设计中的影响。
Expert Opin Drug Discov. 2012 Oct;7(10):863-75. doi: 10.1517/17460441.2012.714363. Epub 2012 Sep 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验